Drug maker Forest Laboratories Inc. and Danish pharmaceutical company H. Lundbeck AS said Thursday a late-stage study met its main goal of showing their Lexapro depression treatment reduces symptoms in adolescents.
From: biz.yahoo.com
Forest Labs, Lundbeck: Study Meets Goal
Posted by Ruslan Abuzant at 8:58 AM
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment